Dan Browne

Dan Browne is a co-founder of the company and has served as our President, Chief Executive Officer and a member of the board of directors since operations commenced in 2002. Prior to starting Revance, Mr. Browne served as President and Chief Executive Officer of Neomend, Inc., a biologics and biomaterials company; he served as President of Prograft Medical Inc., a developer of peripheral vascular stents and stent-grafts. Previously, Mr. Browne spent more than 16 years in various leadership positions in product development, sales and marketing and business development in the GORE-TEX Medical Products Division of W.L. Gore & Associates, Inc., a global technology company, serving as Business Leader in the Medical Products Division as his final role at the company.